Cabotib 60MG Tablet (30’s) is a prescription medication that contains Cabozantinib as its active ingredient, specifically formulated to treat certain types of cancer. This drug is primarily indicated for patients with advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer) who have previously undergone other treatments. Cabozantinib works by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and metastasis, thereby slowing down the progression of cancer. Each tablet contains 60 mg of Cabozantinib, and the medication is typically prescribed as part of a comprehensive cancer treatment plan. Patients taking Cabotib should be closely monitored for side effects and treatment efficacy, making it essential to follow the healthcare provider’s instructions carefully.